Sale!

Chimerism Preengraftment Donor Recipient Test

Original price was: $450.Current price is: $326.

-28%

The Chimerism Preengraftment Donor Recipient Test is a crucial molecular diagnostic tool used to monitor the success of bone marrow or stem cell transplantation. This advanced PCR-based analysis detects and quantifies the percentage of donor-derived cells in the recipient’s bloodstream during the critical early post-transplant period. By measuring the degree of chimerism, healthcare providers can assess engraftment success, detect early signs of graft failure, and monitor for potential relapse. The test requires blood samples from both donor and recipient, with results available in 10-12 days. At just $326 USD, this essential monitoring test provides vital information for transplant success and patient management.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Chimerism Preengraftment Donor Recipient Test

Comprehensive Introduction to Chimerism Testing

The Chimerism Preengraftment Donor Recipient Test represents a cornerstone in modern transplant medicine, providing critical insights into the success of bone marrow and stem cell transplantation procedures. This sophisticated molecular diagnostic test evaluates the establishment of donor-derived hematopoietic cells in the recipient’s system during the crucial early post-transplant phase. Understanding chimerism levels is essential for transplant physicians to make informed decisions about patient management and treatment adjustments.

What Does This Test Measure and Detect?

This advanced diagnostic test utilizes PCR-based STR (Short Tandem Repeat) fragment analysis to precisely quantify the percentage of donor cells present in the recipient’s bloodstream. The test specifically measures:

  • Percentage of donor-derived hematopoietic cells
  • Degree of engraftment success
  • Early detection of mixed chimerism patterns
  • Monitoring of donor cell proliferation
  • Assessment of transplant stability

Technical Methodology

Using state-of-the-art PCR and STR fragment analysis, the test compares genetic markers from both donor and recipient samples to determine the exact proportion of donor cells. This molecular approach provides highly accurate and reproducible results, making it the gold standard for chimerism monitoring in transplant medicine.

Who Should Consider This Test?

This test is specifically designed for patients undergoing or having recently undergone:

  • Bone marrow transplantation procedures
  • Stem cell transplantation treatments
  • Hematopoietic cell transplantation
  • Patients at risk for graft failure
  • Individuals requiring post-transplant monitoring

Clinical Indications Include:

  • Monitoring early engraftment success
  • Detecting potential graft rejection
  • Assessing donor cell establishment
  • Monitoring for disease relapse
  • Evaluating transplant stability

Significant Benefits of Chimerism Testing

Undergoing chimerism testing provides numerous advantages for transplant patients and their healthcare teams:

  • Early Intervention Opportunities: Detect potential complications before they become critical
  • Treatment Optimization: Guide immunosuppressive therapy adjustments
  • Prognostic Information: Provide valuable insights into transplant outcomes
  • Peace of Mind: Offer reassurance about transplant success
  • Personalized Care: Enable tailored treatment approaches based on individual response

Understanding Your Test Results

Your chimerism test results will provide crucial information about your transplant status:

Complete Chimerism

Indicates successful establishment of donor cells with minimal or no recipient cells detected. This represents the ideal outcome for most transplant scenarios.

Mixed Chimerism

Shows the presence of both donor and recipient cells. The specific percentage breakdown helps guide treatment decisions and monitor for potential complications.

Declining Chimerism

A decrease in donor cell percentage may indicate graft rejection or disease relapse, requiring immediate medical attention and intervention.

Test Pricing Information

Test Name Discount Price Regular Price
Chimerism Preengraftment Donor Recipient Test $326 USD $450 USD

Sample Requirements and Processing

Turnaround Time: 10-12 days

Sample Type: 4 ml (2 ml minimum) whole blood in 1 Lavender Top (EDTA) tube each for Donor and Recipient. Ship refrigerated. DO NOT FREEZE. Clearly indicate “Donor” and “Recipient” on tubes appropriately.

Pre-test Instructions: No special preparation required

Nationwide Testing Availability

We have branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our extensive network ensures convenient access to this essential transplant monitoring test regardless of your location.

Take Control of Your Transplant Journey

Don’t leave your transplant success to chance. The Chimerism Preengraftment Donor Recipient Test provides the critical data needed to ensure your transplant achieves optimal outcomes. Our experienced molecular diagnostics team, specialized in transplantation pathology, delivers accurate, reliable results that transplant physicians trust.

Ready to Schedule Your Test?

Call our dedicated transplant testing specialists today at +1(267) 388-9828 to book your Chimerism Preengraftment Donor Recipient Test. Our team will guide you through the simple process and answer any questions you may have about this essential transplant monitoring procedure.

Why Choose Our Testing Services?

  • Expertise in molecular diagnostics and transplantation pathology
  • Rapid 10-12 day turnaround time
  • Competitive pricing at only $326 USD
  • Nationwide testing availability
  • Comprehensive result interpretation support
  • Collaboration with your transplant medical team